Table 4:
Adverse event | Group; no. of patients | p value† | |
---|---|---|---|
Prednisolone n = 88 |
Placebo n = 86 |
||
First week | |||
Gastric complaint | 11/86 | 8/84 | 0.5 |
Diarrhea | 14/86 | 10/85 | 0.4 |
Increased appetite | 14/86 | 7/84 | 0.1 |
Mood disturbance | 13/83 | 15/85 | 0.7 |
Sleep disturbance | 24/85 | 28/86 | 0.5 |
Second week | |||
Gastric complaint | 7/88 | 5/85 | 0.6 |
Diarrhea | 12/87 | 8/86 | 0.4 |
Increased appetite | 8/87 | 3/85 | 0.1 |
Mood disturbance | 9/88 | 11/84 | 0.6 |
Sleep disturbance | 12/87 | 15/85 | 0.5 |
Two serious adverse events not related to drug use were reported: 1 hospital admission for anemia on day 49 of the study in the placebo group and 1 hospital admission for wasp sting–induced anaphylaxis on day 28 of the study in the prednisolone group.
χ2 test.